| Literature DB >> 23285111 |
Prasad K Padmanabhan1, Carole Dumas, Mukesh Samant, Annie Rochette, Martin J Simard, Barbara Papadopoulou.
Abstract
In contrast to nearly all eukaryotes, the Old World Leishmania species L. infantum and L. major lack the bona fide RNAi machinery genes. Interestingly, both Leishmania genomes code for an atypical Argonaute-like protein that possesses a PIWI domain but lacks the PAZ domain found in Argonautes from RNAi proficient organisms. Using sub-cellular fractionation and confocal fluorescence microscopy, we show that unlike other eukaryotes, the PIWI-like protein is mainly localized in the single mitochondrion in Leishmania. To predict PIWI function, we generated a knockout mutant for the PIWI gene in both L. infantum (Lin) and L. major species by double-targeted gene replacement. Depletion of PIWI has no effect on the viability of insect promastigote forms but leads to an important growth defect of the mammalian amastigote lifestage in vitro and significantly delays disease pathology in mice, consistent with a higher expression of the PIWI transcript in amastigotes. Moreover, amastigotes lacking PIWI display a higher sensitivity to apoptosis inducing agents than wild type parasites, suggesting that PIWI may be a sensor for apoptotic stimuli. Furthermore, a whole-genome DNA microarray analysis revealed that loss of LinPIWI in Leishmania amastigotes affects mostly the expression of specific subsets of developmentally regulated genes. Several transcripts encoding surface and membrane-bound proteins were found downregulated in the LinPIWI((-/-)) mutant whereas all histone transcripts were upregulated in the null mutant, supporting the possibility that PIWI plays a direct or indirect role in the stability of these transcripts. Although our data suggest that PIWI is not involved in the biogenesis or the stability of small noncoding RNAs, additional studies are required to gain further insights into the role of this protein on RNA regulation and amastigote development in Leishmania.Entities:
Mesh:
Substances:
Year: 2012 PMID: 23285111 PMCID: PMC3528672 DOI: 10.1371/journal.pone.0052612
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1The Leishmania PIWI-like protein homolog forms a distinct group of the Argonaute/PIWI subfamily.
(A) Structural domains (N-term, PAZ, MID, PIWI) of the Argonaute/PIWI proteins in higher eukaryotes (e.g. Drosophila) and in the unicellular parasitic protozoan Leishmania. In Leishmania only the C-terminal PIWI domain is found (residues 899–1221). The Leishmania PIWI-like homolog contains a small domain (residues 450–492, hatched box) with homology to the mitochondrial cytochrome C oxidase subunit VIIIb. A signal peptide of 24 residues has been predicted at the N-terminus of the Leishmania PIWI-like homolog. (B) Multiple sequence alignment of PIWI domains from L. major, the related trypanosomatids Trypanosoma cruzi and T. brucei, H. sapiens HIWI and the Drosophila melanogaster PIWI. The alignment was conducted using the Bioedit program [74]. Residues that are universally invariable among all eukaryotic Argonaute (AGO) proteins are shaded black. Residues that are highly conserved in all AGO proteins are shaded grey. Divalent anion-binding residues (Gln and Leu; residues 952 and 1242) are indicated by open arrows and the catalytic AGO triad (DDH; residues 981, 1048 and 1210) are indicated by black arrows. In the Drosophila PIWI homolog, the histidine (H) residue of DDH is not conserved but instead a lysine residue is present (DDK). The glutamate at position 1061, part of the RNase H-like DDE motif, is indicated by an asterisk. Residues putatively involved in RNA binding are underlined by a black rectangle. The C-terminus hydrophobic residues are boxed.
Figure 2The Leishmania PIWI transcript is preferentially expressed in the amastigote lifestage.
Northern blot hybridization to measure expression of the L. infantum LinPIWI transcript in exponentially- and stationary-grown promastigotes (Pro) and also in axenic amastigotes (Ama). The 5S rRNA probe was used for normalization of RNA loading. Northern blot experiments have been repeated two more times with identical results.
Figure 3The Leishmania PIWI-like protein is mainly localized in the mitochondrion.
(A) Localization of PIWI-GFP protein was monitored in both L. infantum promastigote (Pro) and axenic amastigote (Ama) forms by confocal microscopy. Mitotracker (a red fluorscent dye) was used to stain the Leishmania single mitochondrion. The green fluorescence signal of GFP was mostly co-localized with that of the Mitotracker. (B) Immunolocalization studies using epifluorescence microscopy to confirm mitochondrial localization of the PIWI-like protein. PIWI largely co-localizes with a known mitochondrial protein, HSP70. (C) Digitonin fractionation was carried out in L. infantum LinHA-PIWI-HA recombinant promastigotes. Western blot of digitonin-fractionated samples (20 µM–10 mM) was probed with an anti-HA antibody to detect the PIWI protein and with anti-HSP70 (cytosolic) and anti-HSP70 (mitochondrial) antibodies used as controls for cytoplasmic and mitochondrial proteins, respectively. The 20 and 200 µM digitonin lanes correspond to cytosolic fractions and the 1 mM and 10 mM lanes correspond to organellar fractions. The pellet fraction contains membrane-associated proteins.
Figure 4Genomic inactivation of the PIWI gene in L. infantum and L. major strains leads to a decrease in amastigote growth and disease pathology.
(A, upper panel) Strategy to inactivate the L. infantum PIWI gene (LinPIWI(−/−)) by genetic replacement. Both alleles of the LinPIWI single copy gene were replaced by the hygromycin phosphotransferase gene (HYG) by a loss of heterozygocity. (A, bottom panel) Southern blot hybridization of L. infantum genomic DNA digested with NcoI using the PIWI 5′ flank sequence as a probe. In LinPIWI(+/+), only a 2.3 kb band which corresponds to the wild type alleles was detected. In LinPIWI(+/−) clones (C1, C2 and C3), in addition to the wild type allele, one more band of 1.0 kb (for the HYG gene integration) was detected. In LinPIWI(−/−), only one band of 1.0 kb (for the HYG gene replacement) was detected but not the 2.3 kb band. (B) Growth curve of L. infantum axenic amastigotes for LinPIWI(+/+) and LinPIWI(−/−) independent clones 3, 5 and 6. The growth pattern of L. infantum WT and LinPIWI(−/−) clones on days 1, 3, 5 and 7 was analyzed by one-way ANOVA followed by a Tukey’s post-test using GraphPad Prism (version 3.03) software. Significant differences between the various groups are indicated (*, P<0.05; **, P<0.01; and ***, P<0.001). (C, left panel) Strategy to generate a PIWI null mutant in L. major (LmjPIWI(−/)). The LmjPIWI alleles were replaced by the HYG expression cassette by a single round of gene targeting. (C, right panel) Southern blot hybridization using the L. major PIWI 5′ flank sequences as a probe. The 17 kb band corresponds to the PIWI wild type alleles and the 1.0 kb band corresponds to the HYG gene integration into the PIWI genomic locus. (D) L. major infection rates in mice estimated by measuring the size of footpad lesions at different time points post-infection in BALB/c mice infected with either the wild type (LmjPIWI(+/+)) strain or the LmjPIWI(−/−) null mutant (clone 1). Control mice were sacrificed at 4 weeks post-infection due to the larger size of the lesions. Data shown here are the mean±SD of 6 mice per group and are representative of three independent experiments. The footpad thickness of L. infantum WT and LmjPIWI(−/−) null mutant on weeks 1, 2, 3 and 4 was analyzed by t-test (non parametric) using GraphPad Prism (version 3.03) software. Significant differences between WT and LmjPIWI(−/−) are indicated (**, P<0.01 and ***, P<0.001).
Genes differentially expressed between Leishmania infantum wild type and LinPIWI(−/−) axenic amastigotes as assessed by DNA microarray analysis.
| Accession number (TriTryp DB)/Biological process | Gene description | Fold difference (Ax. Ama/Pro) |
| Stage-specific gene expression |
|
| ||||
|
| ||||
| LinJ.04.0200 | surface antigen-like protein | 0.5824 | 4,32E−04 | Amastigote |
| LinJ.05.0900 | surface antigen-like protein | 0.5561 | 4,58E−04 | Amastigote |
| LinJ.36.2720 | membrane bound acid phosphatase 2, putative | 0.5375 | 2,59E−05 | Promastigote |
| LinJ.33.0310 | glucose transporter/membrane transporter D2, putative | 0.4638 | 4,20E−05 | Amastigote |
| LinJ.07.1340 | amino acid transporter, putative (AAT19) | 0.4731 | 1,22E−05 | Amastigote |
| LinJ.10.0490, LinJ.10.0500, LinJ.10.0510, LinJ.10.0520, LinJ.10.0530 | GP63, leishmanolysin | 0.5641 | 4,20E−04 | Promastigote |
| LinJ.28.0600, LinJ.28.0610 | major surface protease GP63, putative, leishmanolysin, putative | 0.5409 | 2,59E−05 | Promastigote |
| LinJ.10.1450 | pteridine transporter, putative | 0.5859 | 2,87E−04 | Amastigote |
| LinJ.19.0870 | folate/biopterin transporter, putative | 0.4271 | 5,65E−05 | Promastigote |
|
| ||||
| LinJ.14.0710 | fatty acid elongase, putative | 0.3810 | 9,45E−06 | Amastigote |
| LinJ.23.1560 | lathosterol oxidase-like protein | 0.5687 | 1,50E−05 | Promastigote |
|
| ||||
| LinJ.16.0920, LinJ.16.0930 | flagellar calcium binding protein, putative | 0.5921 | 7,57E−04 | Amastigote |
|
| ||||
| LinJ.17.0130 | receptor-type adenylate cyclase, putative | 0.5439 | 4,32E−04 | Amastigote |
|
| ||||
| LinJ.08.0670 | protein kinase, putative | 0.5228 | 2,95E−05 | Amastigote |
| LinJ.04.1230 | protein kinase, putative, casein kinase I, putative | 0.5050 | 2,93E−04 | Amastigote |
| LinJ.36.2420 | protein kinase, putative, serine/threonine protein kinase, putative | 0.5683 | 2,48E−03 | Amastigote |
| LinJ.27.1680 | casein kinase I-like protein | 0.5586 | 8,69E−05 | Amastigote |
|
| ||||
| LinJ.30.3690 | CYC2-like protein, putative | 0.5706 | 5,48E−04 | Amastigote |
|
| ||||
| LinJ.18.0080 | hypothetical protein, conserved | 0.4548 | 2,59E−05 | Amastigote |
| LinJ.18.0140 | hypothetical protein, conserved | 0.5865 | 9,24E−04 | Constitutive |
| LinJ.19.0560 | hypothetical protein, conserved | 0.4814 | 5,65E−05 | Promastigote |
| LinJ.19.0570 | hypothetical protein, conserved | 0.4814 | 5,65E−05 | Amastigote |
| LinJ.06.1360 | hypothetical protein, conserved | 0.4125 | 2,32E−04 | Amastigote |
| LinJ.10.0280 | hypothetical protein, conserved | 0.5471 | 4,25E−04 | Promastigote |
| LinJ.07.0850 | hypothetical protein, unknown function | 0.4690 | 1,69E−04 | Amastigote |
| LinJ.36.0630 | hypothetical protein, unknown function | 0.5452 | 6,11E−04 | Amastigote |
| LinJ.23.0700 | hypothetical protein | 0.5694 | 1,78E−04 | Constitutive |
| LinJ.23.1190 | hypothetical protein, unknown function | 0.5340 | 3,33E−04 | Promastigote |
| LinJ.26.2710 | hypothetical protein, unknown function | 0.5522 | 8,69E−05 | Amastigote |
| LinJ.27.0960 | hypothetical protein, conserved | 0.5425 | 4,93E−04 | Promastigote |
| LinJ.29.2940 | hypothetical protein, conserved/RNA bndingprotein RBP6 | 0.3800 | 1,22E−05 | Promastigote |
| LinJ.31.0750 | hypothetical protein, conserved/Major facilitator superfamily | 0.4655 | 9,55E−05 | Amastigote |
| LinJ.36.4050 | similar to | 0.5921 | 2,93E−04 | Amastigote |
| LinJ.21.0470 | argonaute-like protein, putative, PIWI-like protein 1, putative | 0.3278 | 3,21E−03 | Amastigote |
|
| ||||
|
| ||||
| LinJ.27.1070 | histone H1, putative | 1.8331 | 2,97E−03 | Amastigote |
| LinJ.27.1120 | histone H1, putative | 1.8331 | 2,97E−03 | Amastigote |
| LinJ.21.1160, LinJ.21.1170 | histone H2A | 1.6954 | 9,88E−04 | Promastigote |
| LinJ.29.1850, LinJ.29.1860, LinJ.29.1870 | histone H2A, putative | 1.6954 | 9,88E−03 | Promastigote |
| LinJ.09.1410 | histone H2B | 2.2143 | 4,83E−04 | Promastigote |
| LinJ.17.1320 | histone H2B | 2.2143 | 4,83E−04 | Promastigote |
| LinJ.19.0030, LinJ.19.0040 | histone H2B | 2.2143 | 4,83E−04 | Promastigote |
| LinJ.10.0920 | histone H3 | 1.9454 | 6,30E−04 | Promastigote |
| LinJ.10.1050, LinJ.10.1070 | histone H3 | 1.9454 | 6,30E−04 | Promastigote |
| LinJ.16.0600, LinJ.16.0610 | histone H3, putative | 1.9454 | 6,30E−04 | Promastigote |
| LinJ.31.3320 | histone H4 | 2.2006 | 1,51E−04 | Promastigote |
| LinJ.15.0010 | histone H4 | 2.2006 | 1,51E−04 | Promastigote |
| LinJ.25.2560 | histone H4 | 2.2006 | 1,51E−04 | Promastigote |
| LinJ.06.0010 | histone H4 | 2.2006 | 1,51E−04 | Promastigote |
| LinJ.35.0020 | histone H4, putative, pseudogene | 2.2006 | 1,51E−04 | Promastigote |
| LinJ.35.1320 | histone H4 | 2.2006 | 1,51E−04 | Promastigote |
| LinJ.36.0020 | histone H4 | 2.2006 | 1,51E−04 | Promastigote |
| LinJ.21.0020 | histone H4 | 2.2006 | 1,51E−04 | Promastigote |
|
| ||||
| LinJ.12.0140 | Alg9-like mannosyltransferase, putative | 1.6925 | 1,51E−03 | Constitutive |
|
| ||||
| LinJ.26.0150, LinJ.26.0160 | 60S ribosomal protein L7, putative | 1.7545 | 1,85E−04 | Constitutive |
|
| ||||
| LinJ.26.0450 | ATPase subunit 9, putative | 1.8391 | 6,26E−03 | Constitutive |
|
| ||||
| LinJ.35.1470 | hypothetical protein, conserved | 1.9454 | 1,75E−04 | Constitutive |
| LinJ.06.0920 | hypothetical protein, conserved | 2.1498 | 1,43E−02 | Constitutive |
| LinJ.08.0440 | hypothetical protein, conserved | 2.5012 | 5,59E−03 | Amastigote |
| LinJ.16.0570 | hypothetical protein, conserved | 2.5899 | 2,67E−03 | Constitutive |
Gene functions are based on Gene Ontology (GO) annotation. The main categories are shown here.
Stage-specific gene expression of the modulated transcripts in the L. infantum LinPIWI(−/−) mutant is based on the data by [38], [44].
There is some discrepancy between the intracellular and axenic amastigote microarray data. These genes seem to be more expressed in promastigotes when comparing L. infantum intracellular amastigotes to promastigotes.
A probe recognizing LinJ.14.0710, LinJ.14.0720¸ LinJ.14.0730, LinJ.14.0740 and LinJ.14.0760 showed that theses genes were more expressed in the amastigote stage. Another probe recognizing LinJ.14.0710 and LinJ.14.0720 showed that theses genes were more expressed in the promastigote stage.
Genes encoding proteins with one to several transmembrane domains.
Figure 5The histone mRNAs are upregulated in the L. infantum PIWI−/− null mutant.
(A) Northern blot hybridization of total RNA isolated from wild type LinPIWI(+/+) and LinPIWI(−/−) axenic amastigotes to evaluate changes in the accumulation of the histone H2B (LinJ.19.0030), H3 (LinJ.10.0920) and H4 (LinJ.21.0020) transcripts. Hybridization was carried out with radiolabeled PIWI ORF and histone ORF probes. There are two bands hybridizing with the H2B and H3 gene probes as reported previously [41], [43]. (B) Northern blot hybridization to confirm upregulation of the H4 transcript in LinPIWI(−/−) amastigotes or in heat-stressed promastigotes compared to unstressed parasites. The 18S RNA blot hybridization and EtBr-stained gels were used as loading controls.
Figure 6Leishmania amastigotes lacking PIWI are more sensitive to apoptosis-like cell death inducing agents.
(A) LinPIWI(−/−) was shown to be highly sensitive to miltefosine (MF). Equal number of L. infantum axenic amastigotes (Ama) of wild type and LinPIWI(−/−) mutant strains were treated with various concentrations of MF for a period of 8 hrs. Drug sensitivity was evaluated by measuring the OD at 600 nm in a 96 well plates. The results are expressed as mean ± SD of biological triplicates and the experiments were conducted twice with similar results. The comparison of growth percentage between L. infantum WT treated with 0, 5, 10, 15, 20 µM of MF and LinPIWI(−/−) treated with 0, 2, 4, 6 and 8 µM of MF, respectively (LinPIWI(−/−) is much more sensitive to MF than WT) was analyzed by t-test (non parametric) using GraphPad Prism (version 3.03) software. Significant differences between WT and LinPIWI(−/−) are indicated (*, P<0.05; ***, P<0.001). (B) Primer extension analysis of L. infantum wild type (LinPIWI(+/+)) and five independent clones (Cl 1–3, Cl 5 and Cl 6) of LinPIWI(−/−) null mutant grown as axenic amastigotes using a forward primer corresponding to nucleotides 101–118 of the sLSU γ rRNA to detect antisense (as) LSU γ rRNA fragmentation.